|
Last Updated: Nov 18, 2006 - 12:32:53 PM |
Latest Research
:
Pharmacology
:
Anticholesterol
Use of statins can improve erectile performance in some
Researchers at the University of Pennsylvania School of Medicine say preliminary results of a small study show promise in improving erectile dysfunction (ED) in men who had shown minimal reaction to Viagra. The study results are published in the March issue of the "Journal of Sexual Medicine."
Feb 22, 2006 - 1:10:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Why some cholesterol-lowering drugs cause hot flashes
In a study appearing in the December 1 issue of the Journal of Clinical Investigation, Stefan Offermanns and colleagues from the University of Heidelberg use various mouse models to show why the cholesterol-lowering agent nicotinic acid also commonly causes flushing or "hot flashes" that, although harmless, often prompts patients to discontinue therapy. The authors found that activation of the nicotinic acid receptor GPR109A by nicotinic acid can produce different responses dependent on the location of this receptor in the body.
Dec 30, 2005 - 4:04:00 PM
Latest Research
:
Pharmacology
:
Anticholesterol
Cholesterol levels and use of statins are not associated with breast cancer risk
Cholesterol levels and use of statins or other lipid-lowering drugs are not associated with breast cancer risk, according to a study in the October 24 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
Oct 25, 2005 - 5:14:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Statins can prevent heart attacks and strokes even in those with low cholesterol
University of Sydney combined detailed results from more than 90,000 participants in 14 previously completed trials involving statin treatments. It shows that many people with lower cholesterol levels could benefit from statin treatment.
Sep 28, 2005 - 7:33:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Statins use associated with 36% reduced risk of fractures
In a large study of elderly, predominately male veterans, statin use was associated with a 36 percent reduction in risk of fracture when compared with no lipid-lowering therapy, according to a study in the September 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Sep 27, 2005 - 6:51:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Cholesterol-lowering statin therapy may improve survival
Cholesterol-lowering statin therapy may improve survival in patients with diastolic heart failure (DHF) according to a paper published in Circulation: Journal of the American Heart Association by cardiologists at Wake Forest University Baptist Medical Center.
Jul 23, 2005 - 1:07:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
FDA Gives Final Approval to Fenofibrate Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Fenofibrate Tablets, 54 mg and 160 mg.
May 19, 2005 - 9:24:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Cholesterol-Lowering Agents May Reduce Breast Cancer Risk
A new study shows that statins � drugs widely used to lower cholesterol levels � may reduce breast cancer risk by more than half.
May 17, 2005 - 1:54:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Niaspan(R) Approved as a Lipid Metabolism Regulator to Raise the "Good" Cholesterol Levels
Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) announced today that, through its Canadian development and commercialization partner, Oryx Pharmaceuticals, Inc. (Oryx), regulatory clearance from Health Canada was granted to market all three doses of Kos' Niaspan(R) product (niacin extended-release tablets) in Canada.
Apr 29, 2005 - 10:03:00 AM
Latest Research
:
Pharmacology
:
Anticholesterol
Class Effect of Statins in Elderly Patients
Evidence has shown that the use of statins after acute myocardial infarction (AMI) is effective in reducing the incidence of both fatal and nonfatal cardiovascular events. Since they belong to the same drug class, they are generally thought to be therapeutically equivalent.
Apr 26, 2005 - 6:55:00 PM
Latest Research
:
Pharmacology
:
Anticholesterol
:
Simvastatin
Statin simvastatin linked to protection against endothelial dysfunction in diabetic rats
Almost two years ago, the diabetes arm of the Heart Protection Study, the largest-ever study using a cholesterol-lowering medication, found that diabetics who took a daily dose of the statin drug simvastatin over five years reduced the risk of a first nonlethal heart attack by 37 percent and risk of a first nonfatal or fatal stroke by 24 percent, regardless of their cholesterol or glucose levels. That is significant, since people with diabetes are two to four times more likely than others to have a coronary event even though their low-density lipid (LDL) cholesterol levels are similar to those in the general population.
Apr 3, 2005 - 10:33:00 AM
<< prev
next >>
|
